Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
This chapter provides a detailed overview of innovative drug delivery strategies in breast cancer therapeutics, emphasizing emerging and futuristic approaches. Current modalities, including conventional chemotherapy, targeted therapies, and hormone treatments, are critically assessed regarding their mechanisms and clinical efficacy. The chapter highlights advancements in drug delivery systems, such as nanotechnology-based formulations, liposomal carriers, and implantable devices, which enhance therapeutic effectiveness and minimize systemic toxicity. Futuristic strategies, particularly precision medicine, are explored for their potential to tailor treatments based on genomic and molecular profiling, thereby optimizing therapeutic responses and reducing adverse effects. The role of nanotechnology in achieving targeted delivery of therapeutics to cancer cells while sparing healthy tissues is examined. Additionally, gene editing technologies, such as CRISPR, are discussed for their ability to selectively modulate cancer-related genes, promising precise and lasting therapeutic effects. The chapter also covers immunotherapeutic innovations, including CAR T-cell therapy and cancer vaccines, which leverage the immune system’s capacity to target and eliminate cancer cells. In summary, this chapter elucidates the transformative potential of novel drug delivery strategies in breast cancer, highlighting the integration of advanced technologies to foster effective, personalized treatment paradigms.
This chapter provides a detailed overview of innovative drug delivery strategies in breast cancer therapeutics, emphasizing emerging and futuristic approaches. Current modalities, including conventional chemotherapy, targeted therapies, and hormone treatments, are critically assessed regarding their mechanisms and clinical efficacy. The chapter highlights advancements in drug delivery systems, such as nanotechnology-based formulations, liposomal carriers, and implantable devices, which enhance therapeutic effectiveness and minimize systemic toxicity. Futuristic strategies, particularly precision medicine, are explored for their potential to tailor treatments based on genomic and molecular profiling, thereby optimizing therapeutic responses and reducing adverse effects. The role of nanotechnology in achieving targeted delivery of therapeutics to cancer cells while sparing healthy tissues is examined. Additionally, gene editing technologies, such as CRISPR, are discussed for their ability to selectively modulate cancer-related genes, promising precise and lasting therapeutic effects. The chapter also covers immunotherapeutic innovations, including CAR T-cell therapy and cancer vaccines, which leverage the immune system’s capacity to target and eliminate cancer cells. In summary, this chapter elucidates the transformative potential of novel drug delivery strategies in breast cancer, highlighting the integration of advanced technologies to foster effective, personalized treatment paradigms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.